These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37509637)

  • 1. Predicting Drug-Gene-Disease Associations by Tensor Decomposition for Network-Based Computational Drug Repositioning.
    Kim Y; Cho YR
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational drug repositioning with attention walking.
    Park JH; Cho YR
    Sci Rep; 2024 May; 14(1):10072. PubMed ID: 38698208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTD-DR: Nonnegative tensor decomposition for drug repositioning.
    Jamali AA; Tan Y; Kusalik A; Wu FX
    PLoS One; 2022; 17(7):e0270852. PubMed ID: 35862409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of drug-disease associations based on reinforcement symmetric metric learning and graph convolution network.
    Luo H; Zhu C; Wang J; Zhang G; Luo J; Yan C
    Front Pharmacol; 2024; 15():1337764. PubMed ID: 38384286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis.
    Yang M; Yang B; Duan G; Wang J
    Front Genet; 2023; 14():1271311. PubMed ID: 37795241
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.
    Liu H; Zhang W; Song Y; Deng L; Zhou S
    J Chem Inf Model; 2020 Apr; 60(4):2367-2376. PubMed ID: 32118415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HeTDR: Drug repositioning based on heterogeneous networks and text mining.
    Jin S; Niu Z; Jiang C; Huang W; Xia F; Jin X; Liu X; Zeng X
    Patterns (N Y); 2021 Aug; 2(8):100307. PubMed ID: 34430926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning by prediction of drug's anatomical therapeutic chemical code via network-based inference approaches.
    Peng Y; Wang M; Xu Y; Wu Z; Wang J; Zhang C; Liu G; Li W; Li J; Tang Y
    Brief Bioinform; 2021 Mar; 22(2):2058-2072. PubMed ID: 32221552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A weighted bilinear neural collaborative filtering approach for drug repositioning.
    Meng Y; Lu C; Jin M; Xu J; Zeng X; Yang J
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning multi-scale heterogenous network topologies and various pairwise attributes for drug-disease association prediction.
    Zhang H; Cui H; Zhang T; Cao Y; Xuan P
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35136910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.